Taro Pharmaceutical Industries has a current ratio of 3.60. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for Taro Pharmaceutical Industries's Current Ratio or its related term are showing as below:
TARO'
s Current Ratio Range Over the Past 10 Years
Min: 2.03 Med: 6.19 Max: 9.56
Current: 3.6
During the past 13 years, Taro Pharmaceutical Industries's highest Current Ratio was 9.56. The lowest was 2.03. And the median was 6.19.
TARO's Current Ratio is ranked better than 76.58% of 1076
companies
in the Drug Manufacturers industry
Industry Median: 1.89
vs TARO: 3.60
Taro Pharmaceutical Industries Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Taro Pharmaceutical Industries Current Ratio Chart
Competitive Comparison of Taro Pharmaceutical Industries's Current Ratio
For the Drug Manufacturers - Specialty & Generic subindustry, Taro Pharmaceutical Industries's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Taro Pharmaceutical Industries's Current Ratio Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Taro Pharmaceutical Industries's Current Ratio distribution charts can be found below:
* The bar in red indicates where Taro Pharmaceutical Industries's Current Ratio falls into.
Taro Pharmaceutical Industries Current Ratio Calculation
The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Taro Pharmaceutical Industries (NYSE:TARO) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Taro Pharmaceutical Industries Current Ratio Related Terms
Thank you for viewing the detailed overview of Taro Pharmaceutical Industries's Current Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Taro Pharmaceutical Industries (Taro Pharmaceutical Industries) Business Description
Taro Pharmaceutical Industries Ltd produces, researches, develops, and markets pharmaceutical products. Its primary focus includes semi-solid formulations, such as creams and ointments, and other dosage forms such as liquids, capsules, and tablets. The company is engaged in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Israel, and Other Countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TARO has been successfully added to your 